Employers Recognize Employee Pet Care Needs
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 29 2026
0mins
Source: CNBC
- Emerging Employee Trend: As U.S. companies mandate a full return to office, pet care is increasingly recognized as a vital short-term support service, with approximately 59 million Americans providing family care in 2024, highlighting the strong demand for pet care.
- Significant Absenteeism Impact: A survey by Wagmo reveals that 75% of pet owners missed work due to pet care issues in the past year, with 26% missing six or more days, indicating a direct impact on employee productivity.
- Expanded Corporate Benefits: Wellthy introduced pet care into its back-up services in 2024, with around 50% of clients offering this benefit, showcasing innovation and adaptability in employee welfare aimed at enhancing satisfaction and retention rates.
- Context of Caregiving Crisis: While pet care may not be the most urgent need, Wellthy's service expansion aligns with the founder's personal caregiving experiences, aiming to alleviate financial and emotional stress for families, thereby improving overall workplace productivity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WOOF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WOOF
Wall Street analysts forecast WOOF stock price to rise
7 Analyst Rating
2 Buy
4 Hold
1 Sell
Hold
Current: 2.720
Low
3.00
Averages
3.55
High
4.53
Current: 2.720
Low
3.00
Averages
3.55
High
4.53
About WOOF
Petco Health and Wellness Company, Inc. is a pet health and wellness company focused on improving the lives of pets, pet parents, and its own Petco partners. It offers pet parents a full spectrum of product choices with products to address ongoing humanization and premiumization trends in the market. It integrates its product offering with its services business, building on the foundation of treating the whole pet, including their physical, mental and social well-being. Its service offering includes veterinary care, grooming, and training. It operates a network of full-service, general practice veterinary hospitals complemented by prescription and insurance offerings. It operates more than 1,500 pet care centers across the United States, Mexico and Puerto Rico and a growing network of on-site veterinary hospitals and mobile veterinary clinics. It offers a complete pet health and wellness ecosystem accessible through its pet care centers and digitally at petco.com and on the Petco app.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Pressure Intensifies: The market is under increasing pressure due to rising interest rates and elevated oil prices, particularly amid a wave of new stock offerings that require investors to sell existing shares to participate, leading to declines in major indexes.
- Employment Report Impact: A stronger-than-expected jobs report has pushed Treasury yields higher, diminishing hopes for near-term rate cuts and further exacerbating market uncertainty, leaving investors concerned about future economic prospects.
- Divergent Tech Stock Performance: With Apple's Worldwide Developers Conference approaching, despite questions surrounding its AI strategy, Cramer believes the company's cautious approach to AI infrastructure spending has proven wise, resulting in its stock outperforming other large tech companies.
- Upcoming SpaceX IPO: As SpaceX is expected to debut on the Nasdaq on June 12, Cramer urges investors to quickly raise the necessary funds to participate in the offering, arguing that the market may struggle to advance as long as new stock pressures exist.
See More
- Market Pressure Factors: Jim Cramer warns that the combination of rising interest rates and elevated oil prices could continue to pressure the market, especially with a wave of upcoming AI-related stock offerings that investors must navigate cautiously.
- Major Index Performance: Following a stronger-than-expected jobs report that pushed Treasury yields higher, all three major indexes closed lower, indicating a diminished hope for near-term rate cuts and impacting investor sentiment negatively.
- Upcoming Earnings Reports: Cramer highlights key earnings reports on the horizon, including Apple's Worldwide Developers Conference, suggesting that Apple's decision to refrain from aggressive AI infrastructure spending may prove wise and could influence its stock performance.
- Impact of SpaceX IPO: Cramer anticipates that SpaceX will debut on the Nasdaq on June 12, urging investors to raise the necessary funds to participate, arguing that the market may struggle to advance until new stock offerings are addressed.
See More
- Strategic Collaboration: Alnylam Pharmaceuticals has entered into a strategic AI partnership with Inceptive Nucleics valued at up to $2 billion, aiming to leverage Inceptive's generative AI models to accelerate the discovery of RNA interference therapeutics, thereby enhancing its competitive edge in the biopharmaceutical sector.
- Market Rebound: Blackstone's shares rose 8% despite the firm limiting withdrawals from its Private Credit fund, indicating investor confidence as the stock is poised to end a three-day losing streak, reflecting a positive sentiment towards asset management firms.
- Stock Volatility: Broadcom's shares tumbled nearly 15% after reporting second-quarter revenue of $22.19 billion, falling short of the $22.27 billion expected by analysts, although CEO Hock Tan reiterated the company's fiscal year 2027 revenue guidance for AI chips to exceed $100 billion, raising concerns about future growth prospects.
- Healthcare Outlook: UnitedHealth's stock climbed 5% following an upgrade from Bank of America from neutral to buy, citing improving medical cost trends and supportive near-term data points that are expected to favorably impact second-quarter earnings, reflecting optimism in the health insurance sector.
See More
- Broadcom's Revenue Miss: Broadcom reported fiscal Q2 revenue of $22.19 billion, falling short of the $22.27 billion expected by analysts, resulting in a 15% stock drop, marking its first revenue miss since December 2024, raising concerns about future growth prospects.
- Semiconductor Stocks Decline: Following Broadcom's disappointing results, shares of AI semiconductor companies fell, with Micron Technology down 6%, Super Micro Computer down 7%, Intel down 4%, and AMD down nearly 5%, reflecting a pessimistic sentiment towards the semiconductor sector's outlook.
- Five Below's Mixed Signals: Despite Five Below's forecast of Q2 revenue between $1.18 billion and $1.2 billion, exceeding the $1.15 billion estimate, its stock fell nearly 11%, indicating investor concerns about the overall retail sector's performance.
- CrowdStrike's Weak Guidance: CrowdStrike anticipates Q2 revenue around $1.44 billion, slightly above the $1.3 billion estimate, but its stock dropped 10%, suggesting skepticism about its growth potential amid lackluster guidance.
See More
- Modest Sales Growth: Petco's Q1 sales increased by only 0.2% to $1.5 billion, indicating a lack of robust growth in a competitive market, despite ongoing growth initiatives.
- Profitability Improvement: The company achieved a gross margin increase of 21 basis points to 38.4%, with operating profit rising 50.5% year-over-year to $24.6 million, showcasing success in cost control and service differentiation.
- Cash Flow Pressure: The first quarter saw a free cash flow outflow of $69 million, primarily due to increased capital expenditures and inventory investments, which may impact the company's future financial flexibility.
- Market Share Challenges: Despite improvements across various categories, Petco has not yet begun to gain market share and faces challenges from external factors such as fuel prices and tariff policies, which could affect future financial performance.
See More
- Sales Growth Resurgence: Petco reported net sales of $1.5 billion in Q1 2026, reflecting a 0.2% year-over-year increase, marking a return to positive comp sales of 0.7%, indicating early validation of its 'Reach for the Sky' strategy and boosting market confidence.
- Profitability Enhancement: Adjusted EBITDA rose by $7.9 million to $97.3 million, an 8.8% year-over-year increase, showcasing effective cost control and operational optimization measures that further solidify the company's financial health.
- Gross Margin Improvement: The first quarter gross profit reached $574.4 million, with the gross margin rate expanding by 21 basis points to 38.4%, indicating positive progress in product pricing and cost management, which aids in enhancing overall profitability.
- Full-Year Outlook Reaffirmed: Management reaffirmed its full-year sales and adjusted EBITDA guidance, expecting net sales to be flat to up 1.5%, demonstrating confidence in future performance while reflecting a cautious stance towards market environment changes.
See More











